Bioalpha Holdings Bhd (XKLS:0179) Days Payable: 20.72 (As of Mar. 2026) — 43% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Bioalpha Holdings Bhd Days Payable?

Bioalpha Holdings Bhd XKLS:0179 Days Payable is 20.72 as of Mar. 2026, which is 43% below its 10-year median of 36.19. The stock has 6 warning signs investors should review. Among 1,889 Consumer Packaged Goods companies, Bioalpha Holdings Bhd ranks worse than 87.03% on this metric.

Bioalpha Holdings Bhd's average Accounts Payable for the three months ended in Mar. 2026 was RM0.54 Mil. Bioalpha Holdings Bhd's Cost of Goods Sold for the three months ended in Mar. 2026 was RM2.36 Mil. Hence, Bioalpha Holdings Bhd's Days Payable for the three months ended in Mar. 2026 was 20.72.

The historical rank and industry rank for Bioalpha Holdings Bhd's Days Payable or its related term are showing as below:

XKLS:0179' s Days Payable Range Over the Past 10 Years
Min: 16.73   Med: 36.19   Max: 46.33
Current: 17.67

During the past 13 years, Bioalpha Holdings Bhd's highest Days Payable was 46.33. The lowest was 16.73. And the median was 36.19.

XKLS:0179's Days Payable is ranked worse than
87.03% of 1889 companies
in the Consumer Packaged Goods industry
Industry Median: 44.15 vs XKLS:0179: 17.67

Bioalpha Holdings Bhd's Days Payable declined from Mar. 2025 (31.68) to Mar. 2026 (20.72). It may suggest that Bioalpha Holdings Bhd accelerated paying its suppliers.


Bioalpha Holdings Bhd Days Payable Historical Data

* Premium members only.

The historical data trend for Bioalpha Holdings Bhd's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioalpha Holdings Bhd Days Payable Chart

Bioalpha Holdings Bhd Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.90 40.62 35.35 16.73 37.02

Bioalpha Holdings Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.68 17.05 18.26 17.86 20.72

XKLS:0179 vs KHC, GIS: Days Payable Comparison

For the Packaged Foods subindustry, Bioalpha Holdings Bhd's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioalpha Holdings Bhd Days Payable vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Bioalpha Holdings Bhd's Days Payable distribution charts can be found below:

* The bar in red indicates where Bioalpha Holdings Bhd's Days Payable falls into.



Bioalpha Holdings Bhd Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Bioalpha Holdings Bhd's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (1.918 + 0.597) / 2 ) / 12.399*365
=1.2575 / 12.399*365
=37.02

Bioalpha Holdings Bhd's Days Payable for the quarter that ended in Mar. 2026 is calculated as:

Days Payable (Q: Mar. 2026 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2025 ) + Accounts Payable (Q: Mar. 2026 )) / count ) / Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=( (0.597 + 0.475) / 2 ) / 2.361*365 / 4
=0.536 / 2.361*365 / 4
=20.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 20.72 mean?
Bioalpha Holdings Bhd (XKLS:0179) has a Days Payable of 20.72 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bioalpha Holdings Bhd and its competitors. This is 43% below median its historical median of 36.19. Over the past decade, Bioalpha Holdings Bhd's Days Payable has ranged from 16.73 to 46.33. According to the industry distribution chart, Bioalpha Holdings Bhd ranks #1644 out of 1889 companies in the Consumer Packaged Goods industry, placing it in the top 87%.
Is Bioalpha Holdings Bhd's Days Payable too high?
Bioalpha Holdings Bhd's current Days Payable of 20.72 is 43% below median its 10-year median of 36.19. Over the past 10 years, this metric has ranged from a low of 16.73 to a high of 46.33. The Consumer Packaged Goods industry median Days Payable is 44.15. Bioalpha Holdings Bhd's value of 20.72 is 53.1% below this industry median. Based on the distribution chart, Bioalpha Holdings Bhd ranks #1644 out of 1889 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers.
How does Bioalpha Holdings Bhd's Days Payable compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Bioalpha Holdings Bhd ranks #1644 out of 1889 companies for Days Payable. This places Bioalpha Holdings Bhd in the lower half of its industry. The industry median Days Payable is 44.15. Bioalpha Holdings Bhd's value of 20.72 is 53.1% below this benchmark. Historically, Bioalpha Holdings Bhd's own Days Payable has ranged from 16.73 to 46.33 over the past decade. While the company's 10-year median is 36.19 vs. the industry median of 44.15, Bioalpha Holdings Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Consumer Packaged Goods company?
The median Days Payable among Consumer Packaged Goods companies is 44.15, based on 1,889 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bioalpha Holdings Bhd's current Days Payable of 20.72 is 53.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bioalpha Holdings Bhd and its competitors. For the Consumer Packaged Goods industry, the median Days Payable is 44.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioalpha Holdings Bhd's current Days Payable is 20.72, which is 43% below median its own 10-year median of 36.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioalpha Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Bioalpha Holdings Bhd (XKLS:0179) is currently considered Significantly Overvalued. The stock's GF Value™ is RM0.01, compared to a current price of RM0.02 — trading 100% above its estimated fair value. The current Days Payable is 20.72, which is 43% below median its 10-year median of 36.19 and 53.1% below the Consumer Packaged Goods industry median of 44.15. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Bioalpha Holdings Bhd (XKLS:0179), the current Days Payable is 20.72 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bioalpha Holdings Bhd Business Description

Address No. 1, Jalan Perindustrian Suntrack, Hub Perindustrian Suntrack, Bandar Baru Bangi, Off Jalan P1A, Seksyen 13, Kajang, SGR, MYS, 43000
Bioalpha Holdings Bhd is a nutraceutical and health supplement group in Malaysia, operates a multi-faceted value chain that includes agricultural development, research and development (R&D), and the manufacturing of functional food and supplement products on an Original Design Manufacturer (ODM) basis. The business operates in segments that include Trading, Manufacturing, Retail pharmacy, and Others. It generates maximum revenue from Manufacturing segment, which involves Research, development, manufacture, importer, exporter, distribution and trader of nutritional and health care products. Geographically, the company derives majority revenue from Malaysia, while it also has its presence in China and Others.